{"id":15342,"date":"2020-10-05T12:05:29","date_gmt":"2020-10-05T16:05:29","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=15342"},"modified":"2020-10-05T12:05:50","modified_gmt":"2020-10-05T16:05:50","slug":"four-ipo-launches-sets-table-for-six-deal-week","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/four-ipo-launches-sets-table-for-six-deal-week\/","title":{"rendered":"Four IPO Launches, Sets Table for Six Deal Week"},"content":{"rendered":"

The first full week of the fourth quarter shaped up with four additional IPOs setting terms for debuts later this week. It amounts to a total of six IPOs on the schedule with all deals debuting either Thursday or Friday.<\/p>\n

\n

For IPO Boutique Research, Ratings and Commentary on all traditional IPO offerings (not direct listings), try us out: http:\/\/www.ipoboutique.com\/blog\/register\/<\/a><\/strong><\/p>\n

IPO Boutique: Indicate with Confidence.<\/em><\/p>\n

\n

\"\"<\/a><\/p>\n

Debuting Thursday 10\/8<\/strong><\/p>\n

\u00a0Aziyo Biologics, Inc. (AZYO) —\u00a0 <\/b>They are a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices.<\/span><\/p>\n

fuboTV Inc. (FUBO) —\u00a0 <\/b>FuboTV is the leading sports-first, live TV streaming platform, offering subscribers access to tens of thousands of live sporting events annually as well as leading news and entertainment content.<\/span><\/p>\n

Debuting Friday 10\/9<\/strong><\/p>\n

iHuman Inc (IH) <\/b>—\u00a0 <\/b>They are a leading childhood edutainment company in China, with core expertise in providing integrated and innovative products and services catering to the education demands for children mainly aged between three and eight.<\/p>\n

Kronos Bio, Inc. (KRON) —<\/b> They are a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.<\/p>\n

Shattuck Labs Inc (STTK) —<\/b>They are an innovative clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine.<\/p>\n

Spruce Biosciences, Inc. (SPRB) —<\/b> They are a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need.<\/p>\n","protected":false},"excerpt":{"rendered":"

The first full week of the fourth quarter shaped up with four additional IPOs setting terms for debuts later this week. It amounts to a total of six IPOs on the schedule with all deals debuting either Thursday or Friday. For IPO Boutique Research, Ratings and Commentary on all traditional IPO offerings (not direct listings),[…]<\/p>\n","protected":false},"author":4,"featured_media":15343,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,2058,1536],"tags":[],"class_list":["post-15342","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","category-spotlight","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/15342","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=15342"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/15342\/revisions"}],"predecessor-version":[{"id":15344,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/15342\/revisions\/15344"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media\/15343"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=15342"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=15342"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=15342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}